Aclaris Therapeutics, Inc.

ACRS

NASDAQ

Healthcare

Medical - Diagnostics & Research

Wayne, PA, US61 employeesaclaristx.com

$4.16

+0.01(0.4%)

52W $1.08 – $4.53

AI-generated

Aclaris Therapeutics, Inc.

Revenue breakdown: License And Service (41.7%), Dermatology Therapeutics Segment (41.7%), Laboratory Research Revenue (8.3%).

$501MMkt Cap

$8MRev TTM

-$64MNI TTM

-6.8xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 25, 2026

10-K for FY2025 was filed on 2026-02-26. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Regulation FDMar 10, 2026

shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li

View filing →

Regulation FDMar 8, 2026

shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li

View filing →

Financial ResultsFeb 25, 2026

and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or oth

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

License And Service41.7%($22M)

Dermatology Therapeutics Segment41.7%($22M)

Laboratory Research Revenue8.3%($4M)

Contract Research Segment8.3%($4M)

Peer Companies

Company	Price	Change	Market Cap	P/E
BIOABioAge Labs, Inc.	$17.46	-1.52%	$628M	-8.8
ALLOAllogene Therapeutics, In...	$2.50	-2.54%	$608M	-2.8
SENSSenseonics Holdings, Inc.	$6.88	+3.46%	$287M	-3.9
CABACabaletta Bio, Inc.	$2.97	+10.82%	$286M	-1.2
EDITEditas Medicine, Inc.	$2.68	+2.68%	$262M	-1.3
MASS908 Devices Inc.	$6.64	+6.92%	$248M	11.4
OMIOMI	$2.68	+8.94%	$207M	—
NEONeoGenomics, Inc.	$7.97	+2.90%	$207M	-1.9

Company Profile

CIK0001557746

ISINUS00461U1051

CUSIP00461U105

Phone484 324 7933

Address640 Lee Road, Wayne, PA, 19087, US

SEC EDGAR